Bicycle Therapeutics plc Income Taxes Paid
Bicycle Therapeutics plc (BCYC) reported Income Taxes Paid of $406.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-07-30
- Bicycle Therapeutics plc income taxes paid, net for the quarter ending 2025-12-31 was $171.00K.
- Bicycle Therapeutics plc income taxes paid, net for the quarter ending 2025-09-30 was $233.00K.
- Bicycle Therapeutics plc income taxes paid, net for the quarter ending 2024-12-31 was $0.00.
- Bicycle Therapeutics plc income taxes paid, net for the quarter ending 2024-09-30 was $0.00.
- Bicycle Therapeutics plc income taxes paid, net for fiscal 2025 was -$717.00K, a 190.53% decline from fiscal 2024.
- Bicycle Therapeutics plc income taxes paid, net for fiscal 2024 was $792.00K, a 40.93% increase from fiscal 2023.
- Bicycle Therapeutics plc income taxes paid, net for fiscal 2023 was $562.00K, a 74.78% decline from fiscal 2022.
- Bicycle Therapeutics plc income taxes paid, net for fiscal 2022 was $2.23M, a 2952.05% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $406.00K 10-Q · filed 2026-07-30 | |||
| 2025-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $404.00K derived: sum of 2 quarters · filed 2026-03-17 | -$717.00K 10-K · filed 2026-03-17 | |
| 2025-09-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$888.00K 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | -$1.12M 10-Q · filed 2026-07-30 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $792.00K 10-K · filed 2026-03-17 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $792.00K 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | $792.00K 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | -$102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$102.00K derived: sum of 2 quarters · filed 2026-03-17 | $562.00K 10-K · filed 2026-03-17 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $664.00K 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | $664.00K 10-Q · filed 2024-08-06 | |||
| 2022-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.48M derived: sum of 2 quarters · filed 2025-02-25 | $2.26M derived: sum of 3 quarters · filed 2025-02-25 | $2.23M 10-K · filed 2025-02-25 |
| 2022-09-30 | $454.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.24M derived: sum of 2 quarters · filed 2023-11-02 | $1.20M 10-Q · filed 2023-11-02 | $1.19M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $784.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $749.00K 10-Q · filed 2023-08-03 | $735.00K derived: sum of 3 quarters · filed 2024-02-20 | $769.00K derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | -$35.00K 10-Q · filed 2023-05-04 | -$49.00K derived: sum of 2 quarters · filed 2024-02-20 | -$15.00K derived: sum of 3 quarters · filed 2024-02-20 | |
| 2021-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $20.00K derived: sum of 2 quarters · filed 2024-02-20 | $73.00K 10-K · filed 2024-02-20 | |
| 2021-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $87.00K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $53.00K 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $86.00K derived: sum of 2 quarters · filed 2023-02-28 | $113.00K derived: sum of 3 quarters · filed 2023-02-28 | $124.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $113.00K derived: sum of 2 quarters · filed 2021-11-04 | $124.00K 10-Q · filed 2021-11-04 | $168.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $38.00K 10-Q · filed 2021-08-05 | $82.00K derived: sum of 3 quarters · filed 2022-03-01 | $82.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $11.00K 10-Q · filed 2021-05-06 | $55.00K derived: sum of 2 quarters · filed 2022-03-01 | $55.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $44.00K derived: sum of 2 quarters · filed 2022-03-01 | $117.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $73.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $73.00K 10-Q · filed 2020-08-05 | |||
| 2018-12-31 | $73.00K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |